DF
DXCM icon

Donoghue Forlines’s DexCom DXCM Stock Holding History

Donoghue Forlines’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Buy
+38,524
New +$2.68M 0.67% 52
2023
Q3 		– Sell
-3,893
Closed -$500K – 235
2023
Q2 		$500K Buy
+3,893
New +$471K 0.16% 126

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Donoghue Forlines's DXCM Position: Q1 2026 in Review

Donoghue Forlines opened a new position in DexCom (DXCM) in Q1 2026: 38,524 shares worth $2.42M. The stake represents 0.67% of the portfolio and ranks #52 among its holdings. This is a return to the name: Donoghue Forlines previously reported a position in DXCM as recently as Q2 2023.

Donoghue Forlines first reported a position in DXCM in Q2 2023 and has held it in 2 quarters since. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Donoghue Forlines held 38,524 shares of DexCom worth $2.42M as of Q1 2026.
  • DexCom was a new Donoghue Forlines position in Q1 2026.
  • DexCom made up 0.67% of Donoghue Forlines's portfolio in Q1 2026, its #52 holding.
  • Donoghue Forlines first reported a position in DexCom in Q2 2023 and has held it in 2 quarters since.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.